Oncothermia / Modulated Electro-Hyperthermia

About this approach

Oncothermia commonly refers to modulated electro-hyperthermia, a technique using radiofrequency energy and specialized equipment. It is one approach within a wider family of heat-based treatments. Its marketing language and proposed biological effects do not make it interchangeable with every established use of hyperthermia. Some clinical studies have investigated adding it to conventional treatment.

Where it fits: Device-specific investigational approach; evidence depends on cancer and regimen

Where this treatment is used

A randomized study in a resource-constrained setting examined mEHT added to chemoradiotherapy for locally advanced cervical cancer. Its follow-up reported improvements in disease-free survival and quality-of-life measures without a significant increase in late toxicity. These findings merit careful consideration, but they address a specific population, treatment context and device approach. Independent confirmation and comparison with current standard care remain important when interpreting device-specific studies. NCI’s broader hyperthermia information explains how methods differ; favorable results for another heating technique cannot fill gaps in the evidence for mEHT.

Procedure and practical considerations

Radiofrequency heating can cause discomfort, hot spots, skin reactions or burns, and concurrent cancer therapy brings its own risks. Eligibility depends on the device, treatment area and medical circumstances. A clinic should screen relevant implants and other contraindications according to the actual equipment instructions.

Clinics reporting this approach

These clinic profiles mention this approach in their published materials. Open a profile to compare locations, services, practical details, and ways to get started.